Lorraine Bernard
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Negative-Pressure Wound Therapy for Open Abdomen in Surgical Reintervention after Curative Surgery of Peritoneal Malignancy Increases the Risk of Recurrence.
Journal: Advances in skin & wound care
Published: October 20, 2023
Efficacy and safety of intravenous bevacizumab on severe bleeding associated with hemorrhagic hereditary telangiectasia: A national, randomized multicenter trial.
Journal: Journal of internal medicine
Published: August 18, 2023
Post-operative weight loss affects 3-year survival in patients with gastric adenocarcinoma after gastrectomy and hyperthermic intraperitoneal chemotherapy.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: June 22, 2022
Microperimetry to predict disease progression in eyes at high risk of age-related macular degeneration disease: The PREVISION study.
Journal: Acta ophthalmologica
Published: June 10, 2022
Obstetrical and neonatal complications in hereditary haemorrhagic telangiectasia: A retrospective study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: November 19, 2021
EFFICACY AND SAFETY OF AFLIBERCEPT FOR THE TREATMENT OF IDIOPATHIC CHOROIDAL NEOVASCULARIZATION IN YOUNG PATIENTS: The INTUITION Study.
Journal: Retina (Philadelphia, Pa.)
Published: October 08, 2021
Safety and efficacy of a strategy of vitamin K antagonist reversal with prothrombin complex concentrates compared to vitamin K in patients with hip fracture.
Journal: Canadian journal of surgery. Journal canadien de chirurgie
Published: June 04, 2021
Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.
Journal: Journal of clinical medicine
Published: April 06, 2020
Clinical predictive factors of unresponsiveness to omalizumab in patients with chronic spontaneous urticaria.
Journal: The British journal of dermatology
Published: February 07, 2020
Last Updated: 09/26/2026